Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency DiseasesHirokazu Kanegane, Toshio Miyawaki, Tadashi Ariga et al.|Journal of Clinical Immunology|2014Cited by 38
Health-Related Quality Of Life Of Japanese Patients With Primary Immunodeficiency Diseases Receiving IgPro20, a 20% Liquid Subcutaneous Immunoglobulin (Hizentra®)Hirokazu Kanegane, Toshio Miyawaki, Kohsuke Imai et al.|Journal of Allergy and Clinical Immunology|2014Cited by 0